Kura Oncology Announces Publication in Blood Highlighting Ziftomenib’s Differentiated Binding Profile and Preclinical Activity

Go back to Kura Oncology Announces Publication in Blood Highlighting Ziftomenib’s Differentiated Binding Profile and Preclinical Activity
(NASDAQ: KURA) Delayed: 13.25 +0.10 (0.76%)
Previous Close $13.15    52 Week High $8.90 
Open $12.94    52 Week Low $2.50 
Day High $13.27    P/E N/A 
Day Low $12.89    EPS $0.00 
Volume 1,313,521